✦ LIBER ✦

866 POSTER A phase II study of intravesical gemcitabine as adjuvant therapy in patients (pts) with superficial bladder carcinoma: final results

Book ID: 118623442
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 148 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(05)81161-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3540 POSTER Postoperative adjuvant gemci

3540 POSTER Postoperative adjuvant gemcitabine plus oxaliplatin (GemOx) chemotherapy followed by chemoradiation in patients with pancreatic carcinoma: mature results of a multicenter phase II study

✍ F. Mornex; T. Andre; C. Louvet; J.F. Seitz; M. Ychou; G. Lledo; J. Balosso; C. P 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Final results of a phase II study ofnab-

Final results of a phase II study ofnab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

✍ Christopher Lobo; Gilberto Lopes; Odalys Baez; Aurelio Castrellon; Annapoorna Fe 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 268 KB

Final results of a phase II trial of fir

Final results of a phase II trial of first-time therapy with gemcitabine (Gemtro®) (G) and carboplatin (C) in patients (pts) with advanced non-small cell lung cancer (NSCLC)

✍ Jovtis, S; Brocato, N; Temperley, G; Balbiani, L; Comba, A.Z; Rondinon, M; Almir 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Gemcitabine and oxaliplatin in the treat

Gemcitabine and oxaliplatin in the treatment of patients with immunotherapy-resistant advanced renal cell carcinoma : Final results of a single-institution Phase II study

✍ Camillo Porta; Matteo Zimatore; Ilaria Imarisio; Anna Natalizi; Andrea Sartore-B 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 3 views

## Abstract ## BACKGROUND Currently, there is no standard treatment for patients with advanced renal cell carcinoma (RCC) who do not experience a response to first‐line immunotherapy. In the current Phase II study, the authors explored the antitumor activity of a combination of gemcitabine and oxa

78 A RANDOMIZED PILOT PHASE II STUDY OF

78 A RANDOMIZED PILOT PHASE II STUDY OF THALIDOMIDE AS ADJUVANT THERAPY IN PATIENT WITH HIGH RECURRENCE RISK HEPATOCELLULAR CARCINOMA

✍ M.-C. Ho; R.-H. Hu; C.-M. Ho; C.-N. Chen; K.-J. Chang; P.-H. Lee 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

470 Final results of a phase II study of

470 Final results of a phase II study of combination with nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy in patients with HER2-negative metastatic breast cancer

✍ S. Glück; C. Lobo; G. Lopes; A. Castrellon; J. Hurley; I. Reis; S. Richman; O. S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB